Study: Hormone therapy may impact results of mammograms, biopsies

02/25/2008 | Forbes

A U.S. study found that patients who received combined hormone replacement therapy for about five years are more likely to have abnormal mammograms and breast biopsies compared with those who received a placebo. The findings suggest that HRT may affect the efficacy of the tests in breast cancer diagnosis. A doctor said women need to be more aware of the risks involved in HRT.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC